Previous investigations, in line with our findings, revealed that vitamin D may down-regulate NF-κB expression in inflammatory diseases, for example, multiple sclerosis (Cantorna et al., 1996), type 1 diabetes (Mathieu et al., 1995), and inflammatory bowel disease (Lim et al., 2005). Here, NFKB1 is linked to multiple sclerosis.